세계의 실시간 PCR 키트 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Real Time PCR Kits was estimated to be worth US$ 2925 million in 2024 and is forecast to a readjusted size of US$ 4757 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Real Time PCR Kits cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Real-Time PCR (Polymerase Chain Reaction) kits are diagnostic or research tools that enable the amplification and simultaneous quantification of nucleic acids (DNA or RNA) in real time. These kits typically include enzymes, primers, probes, and buffer systems optimized for fluorescence-based detection. They are widely used in molecular diagnostics, including infectious disease detection (e.g., COVID-19, HIV), cancer gene expression analysis, genetic mutation screening, and food safety testing.

The Real-Time PCR kits market is driven by the growing demand for rapid, accurate, and high-throughput diagnostic tools in clinical, research, and industrial applications. The widespread use of real-time PCR during the COVID-19 pandemic significantly expanded its global adoption and infrastructure. Additionally, increasing investments in molecular diagnostics, rising incidences of infectious diseases, genetic disorders, and cancer, as well as advancements in multiplexing and portable PCR technologies, continue to boost the market. The growing emphasis on personalized medicine and early disease detection also supports long-term demand.

Despite its widespread use, the real-time PCR kits market faces several challenges, including high cost of reagents and instruments, especially in resource-limited settings. Moreover, technical complexity, need for skilled personnel, and the risk of contamination can affect test reliability. The market is also becoming increasingly competitive, with pressure from emerging technologies such as digital PCR and isothermal amplification methods, which offer enhanced sensitivity and simpler workflows. Regulatory hurdles and the need for continuous innovation in assay design further add to the barriers for new entrants.

The classification of Real Time PCR Kits includes Two-step Real Time PCR and One-step Real Time PCR, and most of Real Time PCR Kits is One-step Real Time PCR, the proportion of imaging in 2024 is about 63.88%. Real Time PCR Kits is widely used for the Infectious Disease, Cancer and others. The most proportion of Real Time PCR Kits is used in the Infectious Disease with the proportion is about 68.27% in 2024. North America is the largest sales place, with a consumption value market share nearly 41.14% in 2024. Following North America, Europe is the second largest sales place with the consumption market share of 26.66%. Market competition is intense. Roche, Abbott, Agilent Technologies, Qiagen, Thermo Fisher Scientific, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report aims to provide a comprehensive presentation of the global market for Real Time PCR Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Real Time PCR Kits by region & country, by Type, and by Application.

The Real Time PCR Kits market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real Time PCR Kits.

Market Segmentation

By Company

• Roche
• Abbott
• Agilent Technologies
• Qiagen
• Thermo Fisher Scientific
• DAAN Gene
• Hologic
• Diagenode
• Bio-Rad
• Takara Bio
• Meridian Bioscience
• Toyobo
• SSI Diagnostica
• Genekam
• BGI
• Sansure Biotech
• YHLO
• ACON

Segment by Type

• One-step Real Time PCR
• Two-step Real Time PCR

Segment by Application

• Infectious Disease
• Cancer
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Real Time PCR Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Real Time PCR Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Real Time PCR Kits in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Real Time PCR Kits Product Introduction
• 1.2 Global Real Time PCR Kits Market Size Forecast
  • 1.2.1 Global Real Time PCR Kits Sales Value (2020-2031)
  • 1.2.2 Global Real Time PCR Kits Sales Volume (2020-2031)
  • 1.2.3 Global Real Time PCR Kits Sales Price (2020-2031)
• 1.3 Real Time PCR Kits Market Trends & Drivers
  • 1.3.1 Real Time PCR Kits Industry Trends
  • 1.3.2 Real Time PCR Kits Market Drivers & Opportunity
  • 1.3.3 Real Time PCR Kits Market Challenges
  • 1.3.4 Real Time PCR Kits Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Real Time PCR Kits Players Revenue Ranking (2024)
• 2.2 Global Real Time PCR Kits Revenue by Company (2020-2025)
• 2.3 Global Real Time PCR Kits Players Sales Volume Ranking (2024)
• 2.4 Global Real Time PCR Kits Sales Volume by Company Players (2020-2025)
• 2.5 Global Real Time PCR Kits Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Real Time PCR Kits Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Real Time PCR Kits Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Real Time PCR Kits
• 2.9 Real Time PCR Kits Market Competitive Analysis
  • 2.9.1 Real Time PCR Kits Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Real Time PCR Kits Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real Time PCR Kits as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 One-step Real Time PCR
  • 3.1.2 Two-step Real Time PCR
• 3.2 Global Real Time PCR Kits Sales Value by Type
  • 3.2.1 Global Real Time PCR Kits Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Real Time PCR Kits Sales Value, by Type (2020-2031)
  • 3.2.3 Global Real Time PCR Kits Sales Value, by Type (%) (2020-2031)
• 3.3 Global Real Time PCR Kits Sales Volume by Type
  • 3.3.1 Global Real Time PCR Kits Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Real Time PCR Kits Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Real Time PCR Kits Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Real Time PCR Kits Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Infectious Disease
  • 4.1.2 Cancer
  • 4.1.3 Other
• 4.2 Global Real Time PCR Kits Sales Value by Application
  • 4.2.1 Global Real Time PCR Kits Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Real Time PCR Kits Sales Value, by Application (2020-2031)
  • 4.2.3 Global Real Time PCR Kits Sales Value, by Application (%) (2020-2031)
• 4.3 Global Real Time PCR Kits Sales Volume by Application
  • 4.3.1 Global Real Time PCR Kits Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Real Time PCR Kits Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Real Time PCR Kits Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Real Time PCR Kits Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Real Time PCR Kits Sales Value by Region
  • 5.1.1 Global Real Time PCR Kits Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Real Time PCR Kits Sales Value by Region (2020-2025)
  • 5.1.3 Global Real Time PCR Kits Sales Value by Region (2026-2031)
  • 5.1.4 Global Real Time PCR Kits Sales Value by Region (%), (2020-2031)
• 5.2 Global Real Time PCR Kits Sales Volume by Region
  • 5.2.1 Global Real Time PCR Kits Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Real Time PCR Kits Sales Volume by Region (2020-2025)
  • 5.2.3 Global Real Time PCR Kits Sales Volume by Region (2026-2031)
  • 5.2.4 Global Real Time PCR Kits Sales Volume by Region (%), (2020-2031)
• 5.3 Global Real Time PCR Kits Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Real Time PCR Kits Sales Value, 2020-2031
  • 5.4.2 North America Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Real Time PCR Kits Sales Value, 2020-2031
  • 5.5.2 Europe Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Real Time PCR Kits Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Real Time PCR Kits Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Real Time PCR Kits Sales Value, 2020-2031
  • 5.7.2 South America Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Real Time PCR Kits Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Real Time PCR Kits Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Real Time PCR Kits Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Real Time PCR Kits Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Real Time PCR Kits Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Real Time PCR Kits Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Real Time PCR Kits Sales Value, 2020-2031
  • 6.3.2 United States Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Real Time PCR Kits Sales Value, 2020-2031
  • 6.4.2 Europe Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Real Time PCR Kits Sales Value, 2020-2031
  • 6.5.2 China Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Real Time PCR Kits Sales Value, 2020-2031
  • 6.6.2 Japan Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Real Time PCR Kits Sales Value, 2020-2031
  • 6.7.2 South Korea Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Real Time PCR Kits Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Real Time PCR Kits Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Real Time PCR Kits Sales Value, 2020-2031
  • 6.9.2 India Real Time PCR Kits Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Real Time PCR Kits Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Roche
  • 7.1.1 Roche Company Information
  • 7.1.2 Roche Introduction and Business Overview
  • 7.1.3 Roche Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Roche Real Time PCR Kits Product Offerings
  • 7.1.5 Roche Recent Development
• 7.2 Abbott
  • 7.2.1 Abbott Company Information
  • 7.2.2 Abbott Introduction and Business Overview
  • 7.2.3 Abbott Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Abbott Real Time PCR Kits Product Offerings
  • 7.2.5 Abbott Recent Development
• 7.3 Agilent Technologies
  • 7.3.1 Agilent Technologies Company Information
  • 7.3.2 Agilent Technologies Introduction and Business Overview
  • 7.3.3 Agilent Technologies Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Agilent Technologies Real Time PCR Kits Product Offerings
  • 7.3.5 Agilent Technologies Recent Development
• 7.4 Qiagen
  • 7.4.1 Qiagen Company Information
  • 7.4.2 Qiagen Introduction and Business Overview
  • 7.4.3 Qiagen Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Qiagen Real Time PCR Kits Product Offerings
  • 7.4.5 Qiagen Recent Development
• 7.5 Thermo Fisher Scientific
  • 7.5.1 Thermo Fisher Scientific Company Information
  • 7.5.2 Thermo Fisher Scientific Introduction and Business Overview
  • 7.5.3 Thermo Fisher Scientific Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Thermo Fisher Scientific Real Time PCR Kits Product Offerings
  • 7.5.5 Thermo Fisher Scientific Recent Development
• 7.6 DAAN Gene
  • 7.6.1 DAAN Gene Company Information
  • 7.6.2 DAAN Gene Introduction and Business Overview
  • 7.6.3 DAAN Gene Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 DAAN Gene Real Time PCR Kits Product Offerings
  • 7.6.5 DAAN Gene Recent Development
• 7.7 Hologic
  • 7.7.1 Hologic Company Information
  • 7.7.2 Hologic Introduction and Business Overview
  • 7.7.3 Hologic Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Hologic Real Time PCR Kits Product Offerings
  • 7.7.5 Hologic Recent Development
• 7.8 Diagenode
  • 7.8.1 Diagenode Company Information
  • 7.8.2 Diagenode Introduction and Business Overview
  • 7.8.3 Diagenode Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Diagenode Real Time PCR Kits Product Offerings
  • 7.8.5 Diagenode Recent Development
• 7.9 Bio-Rad
  • 7.9.1 Bio-Rad Company Information
  • 7.9.2 Bio-Rad Introduction and Business Overview
  • 7.9.3 Bio-Rad Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Bio-Rad Real Time PCR Kits Product Offerings
  • 7.9.5 Bio-Rad Recent Development
• 7.10 Takara Bio
  • 7.10.1 Takara Bio Company Information
  • 7.10.2 Takara Bio Introduction and Business Overview
  • 7.10.3 Takara Bio Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Takara Bio Real Time PCR Kits Product Offerings
  • 7.10.5 Takara Bio Recent Development
• 7.11 Meridian Bioscience
  • 7.11.1 Meridian Bioscience Company Information
  • 7.11.2 Meridian Bioscience Introduction and Business Overview
  • 7.11.3 Meridian Bioscience Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Meridian Bioscience Real Time PCR Kits Product Offerings
  • 7.11.5 Meridian Bioscience Recent Development
• 7.12 Toyobo
  • 7.12.1 Toyobo Company Information
  • 7.12.2 Toyobo Introduction and Business Overview
  • 7.12.3 Toyobo Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Toyobo Real Time PCR Kits Product Offerings
  • 7.12.5 Toyobo Recent Development
• 7.13 SSI Diagnostica
  • 7.13.1 SSI Diagnostica Company Information
  • 7.13.2 SSI Diagnostica Introduction and Business Overview
  • 7.13.3 SSI Diagnostica Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 SSI Diagnostica Real Time PCR Kits Product Offerings
  • 7.13.5 SSI Diagnostica Recent Development
• 7.14 Genekam
  • 7.14.1 Genekam Company Information
  • 7.14.2 Genekam Introduction and Business Overview
  • 7.14.3 Genekam Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Genekam Real Time PCR Kits Product Offerings
  • 7.14.5 Genekam Recent Development
• 7.15 BGI
  • 7.15.1 BGI Company Information
  • 7.15.2 BGI Introduction and Business Overview
  • 7.15.3 BGI Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 BGI Real Time PCR Kits Product Offerings
  • 7.15.5 BGI Recent Development
• 7.16 Sansure Biotech
  • 7.16.1 Sansure Biotech Company Information
  • 7.16.2 Sansure Biotech Introduction and Business Overview
  • 7.16.3 Sansure Biotech Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Sansure Biotech Real Time PCR Kits Product Offerings
  • 7.16.5 Sansure Biotech Recent Development
• 7.17 YHLO
  • 7.17.1 YHLO Company Information
  • 7.17.2 YHLO Introduction and Business Overview
  • 7.17.3 YHLO Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 YHLO Real Time PCR Kits Product Offerings
  • 7.17.5 YHLO Recent Development
• 7.18 ACON
  • 7.18.1 ACON Company Information
  • 7.18.2 ACON Introduction and Business Overview
  • 7.18.3 ACON Real Time PCR Kits Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 ACON Real Time PCR Kits Product Offerings
  • 7.18.5 ACON Recent Development

8 Industry Chain Analysis

• 8.1 Real Time PCR Kits Industrial Chain
• 8.2 Real Time PCR Kits Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Real Time PCR Kits Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Real Time PCR Kits Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer